Relative Bio-availability Study of Dolutegravir and Lamivudine Fixed Dose Combinations
Clinical trial NCT02738931 · COMPLETED
Trial details
- NCT number
- NCT02738931
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2016-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.